世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ウイルスフィルター市場。世界の産業動向、シェア、サイズ、成長、機会、および2021-2026年の予測


Virus Filtration Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

The global virus filtration market grew at a CAGR of around 11% during 2015-2020. Looking forward, IMARC Group expects the market to exhibit strong growth during 2021-2026. Keeping in mind the unce... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
IMARC Services Private Limited.
アイマークサービス
2021年11月10日 US$2,299
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
145 英語

 

サマリー

The global virus filtration market grew at a CAGR of around 11% during 2015-2020. Looking forward, IMARC Group expects the market to exhibit strong growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Virus filtration is an effective, non-destructive, and easy to use method of retaining both enveloped and non-enveloped virus particles on the surface or within the pores of a polymeric membrane. It finds extensive applications in continuous bioprocessing, which is gaining traction in monoclonal antibodies (MAbs) for providing small facility footprints. As it does not impact the product quality, it is considered an ideal solution for manufacturing biological products, such as vaccines, somatic cells, gene therapy, and recombinant therapeutic proteins, and enhancing their safety. It is also used to remove blood-borne pathogens from plasma-derived products.

The urgent need for potential therapies and vaccines to treat coronavirus disease (COVID-19) patients under critical conditions is promoting the application of virus filtration in the convalescent plasma for reducing inflammatory mediators. Moreover, advancements in bioprocessing technologies, including single-use equipment, perfusion reactors, and chromatography resins, are positively influencing the adoption of virus filtration in the manufacturing of various biotherapeutic products. The increasing demand for these products can be associated with the significant rise in the prevalence of chronic diseases worldwide. Additionally, regulatory agencies of numerous countries have mandated virus control at various stages of the drug manufacturing process to ensure the virological safety of biological therapeutics, which is also contributing to the market growth. Apart from this, the introduction of an advanced asymmetric membrane structure that provides no impact on virus retention through pressure variations, high loads, or process interruptions is anticipated to stimulate the market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global virus filtration market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product, application and end use.

Breakup by Product:

Consumables
Kits and Reagents
Others
Instruments
Filtration Systems
Chromatography Systems
Services

Breakup by Application:

Biologicals
Vaccines and Therapeutics
Blood and Blood Products
Cellular and Gene Therapy Products
Others
Medical Devices
Water Purification
Air Purification
Others

Breakup by End Use:

Biopharmaceutical and Biotechnology Companies
Contract Research Organizations
Academic Institutes and Research Laboratories
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Asahi Kasei Medical Co. Ltd., Charles River Laboratories, Inc., Clean Cells, Danaher Corporation, Merck KGaA, Sartorius AG and Thermo Fisher Scientific Inc. Key Questions Answered in This Report:
How has the global virus filtration market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global virus filtration market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end use?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global virus filtration market and who are the key players?
What is the degree of competition in the industry?

ページTOPに戻る


目次

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Virus Filtration Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Consumables
6.1.1 Market Trends
6.1.2 Major Types
6.1.2.1 Kits and Reagents
6.1.2.2 Others
6.1.3 Market Forecast
6.2 Instruments
6.2.1 Market Trends
6.2.2 Major Types
6.2.2.1 Filtration Systems
6.2.2.2 Chromatography Systems
6.2.3 Market Forecast
6.3 Services
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Application
7.1 Biologicals
7.1.1 Market Trends
7.1.2 Major Types
7.1.2.1 Vaccines and Therapeutics
7.1.2.2 Blood and Blood Products
7.1.2.3 Cellular and Gene Therapy Products
7.1.2.4 Others
7.1.3 Market Forecast
7.2 Medical Devices
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Water Purification
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Air Purification
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by End Use
8.1 Biopharmaceuticals and Biotechnology Companies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Contract Research Organizations
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Academic Institutes and Research Laboratories
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Asahi Kasei Medical Co. Ltd.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Charles River Laboratories Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Clean Cells
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.4 Danaher Corporation
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Merck KGaA
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Sartorius AG
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Thermo Fisher Scientific Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis

 

ページTOPに戻る


 

Summary

The global virus filtration market grew at a CAGR of around 11% during 2015-2020. Looking forward, IMARC Group expects the market to exhibit strong growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Virus filtration is an effective, non-destructive, and easy to use method of retaining both enveloped and non-enveloped virus particles on the surface or within the pores of a polymeric membrane. It finds extensive applications in continuous bioprocessing, which is gaining traction in monoclonal antibodies (MAbs) for providing small facility footprints. As it does not impact the product quality, it is considered an ideal solution for manufacturing biological products, such as vaccines, somatic cells, gene therapy, and recombinant therapeutic proteins, and enhancing their safety. It is also used to remove blood-borne pathogens from plasma-derived products.

The urgent need for potential therapies and vaccines to treat coronavirus disease (COVID-19) patients under critical conditions is promoting the application of virus filtration in the convalescent plasma for reducing inflammatory mediators. Moreover, advancements in bioprocessing technologies, including single-use equipment, perfusion reactors, and chromatography resins, are positively influencing the adoption of virus filtration in the manufacturing of various biotherapeutic products. The increasing demand for these products can be associated with the significant rise in the prevalence of chronic diseases worldwide. Additionally, regulatory agencies of numerous countries have mandated virus control at various stages of the drug manufacturing process to ensure the virological safety of biological therapeutics, which is also contributing to the market growth. Apart from this, the introduction of an advanced asymmetric membrane structure that provides no impact on virus retention through pressure variations, high loads, or process interruptions is anticipated to stimulate the market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global virus filtration market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product, application and end use.

Breakup by Product:

Consumables
Kits and Reagents
Others
Instruments
Filtration Systems
Chromatography Systems
Services

Breakup by Application:

Biologicals
Vaccines and Therapeutics
Blood and Blood Products
Cellular and Gene Therapy Products
Others
Medical Devices
Water Purification
Air Purification
Others

Breakup by End Use:

Biopharmaceutical and Biotechnology Companies
Contract Research Organizations
Academic Institutes and Research Laboratories
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Asahi Kasei Medical Co. Ltd., Charles River Laboratories, Inc., Clean Cells, Danaher Corporation, Merck KGaA, Sartorius AG and Thermo Fisher Scientific Inc. Key Questions Answered in This Report:
How has the global virus filtration market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global virus filtration market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end use?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global virus filtration market and who are the key players?
What is the degree of competition in the industry?

ページTOPに戻る


Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Virus Filtration Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Consumables
6.1.1 Market Trends
6.1.2 Major Types
6.1.2.1 Kits and Reagents
6.1.2.2 Others
6.1.3 Market Forecast
6.2 Instruments
6.2.1 Market Trends
6.2.2 Major Types
6.2.2.1 Filtration Systems
6.2.2.2 Chromatography Systems
6.2.3 Market Forecast
6.3 Services
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Application
7.1 Biologicals
7.1.1 Market Trends
7.1.2 Major Types
7.1.2.1 Vaccines and Therapeutics
7.1.2.2 Blood and Blood Products
7.1.2.3 Cellular and Gene Therapy Products
7.1.2.4 Others
7.1.3 Market Forecast
7.2 Medical Devices
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Water Purification
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Air Purification
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by End Use
8.1 Biopharmaceuticals and Biotechnology Companies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Contract Research Organizations
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Academic Institutes and Research Laboratories
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Asahi Kasei Medical Co. Ltd.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Charles River Laboratories Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Clean Cells
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.4 Danaher Corporation
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Merck KGaA
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Sartorius AG
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Thermo Fisher Scientific Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


IMARC Services Private Limited.社はどのような調査会社ですか?


インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21 10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る